CJC Peptide Purity Specs Sourcing Guide for Formulators

For formulators seeking reliable CJC peptide sourcing, purity specifications directly impact research outcomes and product consistency. This guide positions CJC peptide as a critical raw material requiring verified HPLC purity above 98%, with endotoxin levels under 1 EU/mg and residual solvent analysis per ICH Q3C standards. Manufacturing must follow cGMP guidelines in ISO-certified facilities to ensure batch-to-batch reproducibility. Key applications include controlled laboratory studies in peptide reconstitution and stability testing. Quality advantages include third-party COA verification, mass spectrometry confirmation, and heavy metal screening below USP limits. Common buyer pain points addressed are inconsistent purity claims, lack of transparent documentation, and variable peptide content that compromises experimental integrity. Prioritizing suppliers who provide full analytical data eliminates sourcing risks.

Core Molecular Specs & Product Technical Index

CJC peptide, specifically referring to the modified analogue of growth hormone releasing hormone (GHRH), is a synthetic peptide chain composed of 29 amino acids. For B2B buyers in the cosmetic and laboratory raw material sectors, the core commercial value lies in its use as a standardized research compound for formulation stability studies and peptide reconstitution protocols. The molecular weight of the standard acetate salt form is approximately 3417.9 Da, with a molecular formula of C152H252N44O42. The product is supplied as a lyophilized white powder, ensuring maximum chemical stability during transport and storage.

Production purity grades are strictly defined by HPLC (High-Performance Liquid Chromatography) analysis. The minimum acceptable purity for research-grade material is 98%, while premium lots often exceed 99%. Solubility characteristics are critical for formulators: CJC peptide is freely soluble in water and sterile saline (0.9% NaCl) at concentrations up to 10 mg/mL, but shows limited solubility in organic solvents. Storage requirements mandate that the lyophilized powder be kept at -20°C, protected from light and moisture, to maintain a shelf life of 24 months. All testing must conform to national pharmacopeia standards, including USP <791> for pH and USP <85> for bacterial endotoxins.

• Purity (HPLC): ≥ 98.0% with single impurity ≤ 0.5%
• Peptide Content: ≥ 80.0% (by nitrogen analysis)
• Endotoxin Level: < 1.0 EU/mg (USP <85> method)
• Residual Solvents: Compliant with ICH Q3C Class 2 & 3 limits
• Heavy Metals: ≤ 10 ppm (USP <231> or ICP-MS)

According to the 2023 Global Peptide Raw Materials Market Report, over 72% of formulation failures in peptide-based research are attributed to raw material purity inconsistencies below 97%, reinforcing the industry's demand for verified HPLC documentation and third-party COA traceability.

Manufacturing Flow & Strict Quality Control System

The manufacturing process for high-grade CJC peptide begins with rigorous raw material screening of Fmoc-protected amino acids, each verified for chiral purity by polarimetry. Solid-phase peptide synthesis (SPPS) is conducted on automated synthesizers in ISO 9001:2015 certified facilities. Following cleavage from the resin, the crude peptide undergoes multi-stage purification via preparative HPLC using a C18 reverse-phase column with a gradient of acetonitrile and water (0.1% TFA). The collected fractions are pooled based on a purity threshold of >98.5%.

Post-purification, the peptide is converted to the acetate salt form through ion-exchange chromatography to improve solubility and stability. The final lyophilization cycle is precisely controlled with a primary drying temperature of -30°C and a secondary drying ramp to +25°C, ensuring residual moisture below 3%. Every production batch is subjected to third-party testing certification, including mass spectrometry (MALDI-TOF) for molecular weight confirmation and amino acid analysis (AAA) for sequence verification. Long-term stability tests are conducted at -20°C, +4°C, and +25°C over 36 months to establish real-time shelf-life data.

Main Certification Standards We Support

• cGMP Compliance: Full batch records and deviation reports per 21 CFR Part 211
• ISO 9001:2015: Quality management system for manufacturing processes
• ISO 17025: Accredited third-party laboratory for analytical testing
• ICH Q3C: Residual solvent analysis with certified reference standards
• USP <232>/<233>: Elemental impurities analysis via ICP-MS

Main Commercial Application Scenarios

CJC peptide serves as a critical raw material in several B2B commercial contexts, primarily within controlled laboratory environments and formulation development. Its application is strictly limited to research and manufacturing purposes, with no claims related to human therapeutic effects. The peptide is typically supplied in bulk quantities ranging from 1 gram to 100 grams for industrial formulation work.

• Cosmetic Formulation Blending: Used as a standardized ingredient in anti-aging serum prototypes at concentrations of 0.01% to 0.05% w/w, requiring compatibility testing with emulsifiers and preservatives.
• Laboratory Research Studies: Employed in cell culture assays for receptor binding studies, typically reconstituted in sterile PBS at pH 7.4 and used within 24 hours of reconstitution.
• Compound Raw Material Wholesale: Supplied as a lyophilized powder for secondary manufacturers who perform custom peptide reconstitution, aliquoting, and labeling for distribution to research institutions.
• Stability Testing Programs: Incorporated into accelerated stability studies at 40°C/75% RH to evaluate degradation kinetics and formulation excipient compatibility.

Comparison: cjc peptide VS Ordinary Low-Grade Peptide Raw Materials

Standard Buyer Selection Guide For Bulk Purchase

Purchasing CJC peptide in bulk quantities presents several common pitfalls that can compromise experimental integrity and formulation consistency. The most frequent issues include inconsistent purity claims between batches, lack of transparent documentation regarding synthetic byproducts, and variable peptide content that leads to inaccurate reconstitution concentrations. To mitigate these risks, buyers must implement a systematic supplier qualification process that prioritizes analytical transparency over price.

Key Inspection Checklist Before Cooperation

• Request Full COA: Verify HPLC chromatogram with peak area percentages for main peak and all impurities above 0.1%.
• Confirm Mass Spec Data: Ensure MALDI-TOF or ESI-MS shows the correct monoisotopic mass within ±1 Da.
• Check Endotoxin Certificate: Require LAL test results with specific EU/mg value, not just "pass" or "fail".
• Review Residual Solvent Report: Confirm GC-MS analysis covers all ICH Q3C Class 2 solvents (acetonitrile, methanol, etc.).
• Audit Manufacturing Facility: Request ISO 9001 certificate and cGMP compliance statement with last audit date.
• Evaluate Stability Data: Ask for real-time stability data at -20°C for at least 12 months.

Core Competitive Advantages Of Our cjc peptide

The primary competitive advantage of our CJC peptide lies in its verified purity consistency across production batches, with a batch-to-batch HPLC variation of less than 0.5%. This is achieved through strict raw material sourcing from USP-grade amino acid suppliers and in-process HPLC monitoring at every purification step. The stability profile is another differentiator: our lyophilized product retains >97% purity after 24 months at -20°C, compared to industry averages of 90-95% for standard grades.

From a cost performance perspective, while our unit price may be 10-15% higher than low-grade alternatives, the effective cost per successful formulation is significantly lower due to reduced batch failures and rework. Our after-sales technical support includes free reconstitution protocols, solubility optimization guidance, and formulation compatibility data for common cosmetic bases. Additionally, we provide a complete documentation package including MSDS, stability summary, and regulatory compliance certificates, which streamlines the buyer's own quality assurance processes and regulatory filings.

Frequently Asked Questions

Q: What is the minimum purity specification for CJC peptide used in cosmetic formulation development?

A: For cosmetic formulation development, the minimum recommended purity specification is 98% by HPLC. This ensures that impurities do not interfere with emulsion stability, pH adjustments, or preservative efficacy testing. Lower purity grades (below 95%) often contain truncated peptide sequences that can cause unpredictable interactions with other formulation ingredients, leading to batch failures and increased development costs.

Q: How should CJC peptide be stored to maintain its chemical integrity for bulk laboratory use?

A: CJC peptide in lyophilized powder form must be stored at -20°C in a freezer with temperature monitoring and alarm systems. The container should be kept tightly sealed with a desiccant pack to prevent moisture absorption. For bulk quantities (5 grams or more), it is recommended to aliquot the powder into single-use vials under nitrogen atmosphere to avoid repeated freeze-thaw cycles. Under these conditions, the peptide maintains >98% purity for at least 24 months.

Q: What documentation should a reliable supplier provide for CJC peptide bulk orders?

A: A reliable supplier must provide a comprehensive Certificate of Analysis (COA) that includes HPLC chromatogram with peak purity data, mass spectrometry confirmation (MALDI-TOF or ESI-MS), amino acid analysis (AAA) for peptide content, endotoxin testing results (LAL method), residual solvent analysis per ICH Q3C, and heavy metal screening (ICP-MS). Additionally, the supplier should provide a Material Safety Data Sheet (MSDS), stability summary report, and a certificate of cGMP compliance for the manufacturing facility.